cadmium has been researched along with Hepatoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begum, RA; Farah, IO; Ishaque, AB | 1 |
| Czaja, MJ; Gagliardi, GS; Gorla, GR; Kesner, A; Miura, N; Schilsky, ML; Stockert, RJ; Terada, K | 1 |
2 other study(ies) available for cadmium and Hepatoblastoma
| Article | Year |
|---|---|
Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin.
Topics: Animals; Arsenic; Benzothiazoles; Cadmium; Cell Line, Tumor; Cells, Cultured; Cytoprotection; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression Regulation; Hepatoblastoma; Hepatocytes; Humans; Lethal Dose 50; Liver Neoplasms; Male; Neoplasm Proteins; Rats; Rats, Wistar; Toluene; Tumor Suppressor Protein p53 | 2007 |
Copper resistant human hepatoblastoma mutant cell lines without metallothionein induction overexpress ATP7B.
Topics: Adenosine Triphosphatases; Blotting, Northern; Blotting, Western; Cadmium; Carrier Proteins; Cation Transport Proteins; Ceruloplasmin; Copper; Copper-Transporting ATPases; Drug Resistance; Gene Expression; Glutathione; Hepatoblastoma; Humans; Kinetics; Liver Neoplasms; Metallothionein; Mutagenesis; Protein Biosynthesis; RNA, Messenger; Tumor Cells, Cultured; Zinc | 1998 |